ApprovalTrail

Drug · DIN 02432889

DYMISTA

SUSPENSION

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since July 31, 2018; first marketed March 31, 2015.
Drug Identification Number (DIN)
02432889
Company (DIN owner)
BGP Pharma ULCEtobicoke, Ontario, Canada
Schedule
Prescription
Dosage form
Spray (Metered-Dose)
Route
Nasal
Therapeutic class (ATC)
Fluticasone, combinations R01AD58
Class
Human
Record last updated
August 14, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
FLUTICASONE PROPIONATE50 MCGACT
AZELASTINE HYDROCHLORIDE137 MCGACT

Notices of Compliance

Health Canada approvals that name this DIN.